Status:
COMPLETED
Treatment of Androgenetic Alopecia in Females, 9 Beam
Lead Sponsor:
Lexington International, LLC
Conditions:
Androgenetic Alopecia
Hair Loss
Eligibility:
FEMALE
25-60 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the efficacy of the HairMax LaserComb 2009 9 beam model in promoting hair growth in females diagnosed with androgenetic alopecia when treatment is applied as d...
Detailed Description
This is a randomized double-blind, control device clinical study across 5 sites, evaluating changes in terminal hair count in the evaluation zone having evidence of androgenetic alopecia (miniaturized...
Eligibility Criteria
Inclusion
- Diagnosis of androgenetic alopecia
- Fitzpatrick Skin Types I-IV
- Ludwig I-4, II-1, II-2, or frontal
- Active hair loss within last 12 months
Exclusion
- Photosensitivity to laser light
- Malignancy in the target area
- Pregnancy
- Lactating females
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00981461
Start Date
October 1 2009
End Date
October 1 2010
Last Update
August 10 2012
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Jose Mendez, DO
Miami, Florida, United States, 33144
2
Abe Marcadis, MD
Palm Beach, Florida, United States
3
David Goldberg, MD
Hackensack, New Jersey, United States
4
Sadick Research Group
New York, New York, United States, 10075